Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Hayes

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
BMJ Mental Health|December 2, 2025
Do the pharmacokinetics of statins explain psychiatric symptom improvement from adjunctive statin prescribing in severe mental illness? Three target trial emulation studiesNaomi Launders, Alvin Richards-Belle, Sarah Hardoon, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2024
Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000-2019: 20-year investigation of who receives treatment, with which agents and at what dosesAlvin Richards-Belle, Naomi Launders, Sarah Hardoon, et al.
Clinical Epidemiology|May 2, 2018
Severe mental illness and chronic kidney disease: a cross-sectional study in the United KingdomMasao Iwagami, Kathryn E Mansfield, Joseph F Hayes, et al.
Clinical Epidemiology|August 14, 2023
Anxiety and Depression in People with Eczema or Psoriasis: A Comparison of Associations in UK Biobank and Linked Primary Care DataJulian Matthewman, Kathryn E Mansfield, Joseph F Hayes, et al.
Nature Communications|December 21, 2025
Risk of major adverse cardiovascular events with aripiprazole versus olanzapine, quetiapine, and risperidone in severe mental illness: a target trial emulationAlvin Richards-Belle, Naomi Launders, Sarah Hardoon, et al.
The Lancet. Psychiatry|June 25, 2019
Tapering of SSRI treatment to mitigate withdrawal symptomsSudhakar Selvaraj, Sameer Jauhar, David S Baldwin, et al.
The Lancet. Psychiatry|September 18, 2025
Antipsychotic prescriptions in people with dementia in primary care: a cohort study investigating adherence of dose and duration to UK clinical guidelinesHolly Christina Smith, Irene Petersen, Joseph F Hayes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 25, 2021
Impact of the COVID-19 pandemic on use of anti-dementia medications in 34 European and North American countriesChengsheng Ju, Wallis C Y Lau, Joseph F Hayes, et al.
Pharmacoepidemiology and Drug Safety|June 28, 2021
Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United KingdomVanessa W S Ng, Kenneth K C Man, Le Gao, et al.
The British Journal of Dermatology|May 24, 2023
Electronic screening for mental illness in patients with psoriasisKatie Bechman, Joseph F Hayes, Julian Mathewman, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
BMJ Mental Health|December 2, 2025
Do the pharmacokinetics of statins explain psychiatric symptom improvement from adjunctive statin prescribing in severe mental illness? Three target trial emulation studiesNaomi Launders, Alvin Richards-Belle, Sarah Hardoon, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2024
Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000-2019: 20-year investigation of who receives treatment, with which agents and at what dosesAlvin Richards-Belle, Naomi Launders, Sarah Hardoon, et al.
Clinical Epidemiology|May 2, 2018
Severe mental illness and chronic kidney disease: a cross-sectional study in the United KingdomMasao Iwagami, Kathryn E Mansfield, Joseph F Hayes, et al.
Clinical Epidemiology|August 14, 2023
Anxiety and Depression in People with Eczema or Psoriasis: A Comparison of Associations in UK Biobank and Linked Primary Care DataJulian Matthewman, Kathryn E Mansfield, Joseph F Hayes, et al.
Nature Communications|December 21, 2025
Risk of major adverse cardiovascular events with aripiprazole versus olanzapine, quetiapine, and risperidone in severe mental illness: a target trial emulationAlvin Richards-Belle, Naomi Launders, Sarah Hardoon, et al.
The Lancet. Psychiatry|June 25, 2019
Tapering of SSRI treatment to mitigate withdrawal symptomsSudhakar Selvaraj, Sameer Jauhar, David S Baldwin, et al.
The Lancet. Psychiatry|September 18, 2025
Antipsychotic prescriptions in people with dementia in primary care: a cohort study investigating adherence of dose and duration to UK clinical guidelinesHolly Christina Smith, Irene Petersen, Joseph F Hayes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 25, 2021
Impact of the COVID-19 pandemic on use of anti-dementia medications in 34 European and North American countriesChengsheng Ju, Wallis C Y Lau, Joseph F Hayes, et al.
Pharmacoepidemiology and Drug Safety|June 28, 2021
Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United KingdomVanessa W S Ng, Kenneth K C Man, Le Gao, et al.
The British Journal of Dermatology|May 24, 2023
Electronic screening for mental illness in patients with psoriasisKatie Bechman, Joseph F Hayes, Julian Mathewman, et al.
Pageof 11